Latest filing published 08 Sept 2010 for GenMark Diagnostics, Inc., €5,969.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Steven J. Kemper: trading record in brief
Steven J. Kemper discloses dealings in 2 companies, chiefly Dexcom Inc and GenMark Diagnostics, Inc. The record holds 7 filings, for trades running from 5 January 2006 to 8 September 2010.
Both buying and selling appear: 3 purchases worth €16k, against 1 sale worth €1.4M. Taken together, the sales exceed the purchases by €1.4M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant and 1 option exercise. So far in 2010, the count stands at 3 purchases and no sales.
The median purchase comes to €5,969.
The record was last updated on 8 September 2010 with an open-market purchase (€5,969) in GenMark Diagnostics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Steven J. Kemper
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,900 shares@ US$4.00Common StockSEC:0001181431-10-046043:0Canonical exit: 7 Dec 2010 (T+90)
- 500 shares@ US$4.18Common StockSEC:0001181431-10-046043:1Canonical exit: 7 Dec 2010 (T+90)
- 2,600 shares@ US$4.19Common StockSEC:0001181431-10-046043:2Canonical exit: 7 Dec 2010 (T+90)
- 26,255 shares0Common StockSEC:0001093557-07-000037:0
- 26,255 shares0Common StockSEC:0001093557-07-000037:1
- 75,000 shares@ US$24.00Common StockSEC:0001005477-06-002508:0
- 25,000 shares@ US$0.50Common StockSEC:0001093557-06-000006:0
7 of 7 declarations
